GlassScriptPhysician profile
Kelechukwu Okoro
NPI 1669869152
$30,371.74
in general payments reported to CMS, 2019-2025
32 companies · $9,561 in 2025
The $9,561 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $728 · 2021: $4,556 · 2022: $2,625 · 2023: $6,986 · 2024: $5,450 · 2025: $9,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $9,482 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,333.25 |
| Food and Beverage | $9,482.11 |
| Education | $180.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,825.91 | 2023-2025 | Perclose Proglide, Optis, Xact |
| Medtronic, INC. | $4,878.11 | 2021-2024 | Resolute Onyx, Onyx Frontier, Corevalve Evolut R |
| Boston Scientific Corporation | $3,446.01 | 2019-2025 | General - Vascular Intervention, General - Therapies |
| Penumbra, INC. | $2,227.20 | 2022-2025 | Indigo System |
| Abiomed | $2,106.73 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $1,558.83 | 2021-2022 | |
| Stryker Corporation | $1,533.28 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $1,168.77 | 2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder |
| Biosense Webster, INC. | $924.05 | 2025 | Carto 3, Nuvision Ice Catheter |
| Astrazeneca Pharmaceuticals LP | $918.27 | 2019-2025 | Wainua, Lokelma |
| Bard Peripheral Vascular, INC. | $848.19 | 2024 | Venclose Maven Catheter, Rotarexs 6 F X 135 Cm |
| Cardiovascular Systems INC. | $793.08 | 2021-2023 | Diamondback Peripheral |
| Medtronic Vascular, INC. | $460.31 | 2020 | |
| Amgen INC. | $398.79 | 2020-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $358.37 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $298.76 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $255.95 | 2022-2025 | Lifevest |
| Philips North America LLC | $206.76 | 2021-2024 | (Bh4) Igt Devices Undivided, (9520) Igt Devices Undivided |
| Actelion Pharmaceuticals US, INC. | $186.90 | 2025 | Uptravi, Opsumit, Opsynvi |
| E.R. Squibb & Sons, L.L.C. | $174.88 | 2023-2024 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.49 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $122.20 | 2022 | |
| United Therapeutics Corporation | $114.30 | 2024 | Tyvaso |
| Inari Medical, INC. | $97.94 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cvrx, INC. | $68.58 | 2024 | Barostim Neo System |
| Cordis US Corp. | $63.74 | 2022 | |
| Novartis Pharmaceuticals Corporation | $38.94 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $36.94 | 2024-2025 | Verquvo |
| Chiesi USA, INC. | $32.72 | 2022 | |
| Glaxosmithkline, LLC. | $25.68 | 2025 | Nucala |
| Alnylam Pharmaceuticals INC. | $16.73 | 2025 | Amvuttra |
| Esperion Therapeutics, INC. | $15.33 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelechukwu Okoro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.